Summary of the main perceptions of general practitioners (GPs) and patients regarding dextropropoxyphene (DXP) withdrawal
| GPs | Patients | |
| DXP medication | Common prescription and use, high risk-benefit ratio, risk of dependence | |
| Valued but non-exclusive strategy | ||
| Reasons for withdrawal | Misunderstanding, trend towards overestimation of benefits and underestimation of risks | |
| Some GPs earlier informed through a professional journal | ||
| Conditions of withdrawal | Information through mainstream media, lack of anticipation | |
| Difficulties to inform patients | DXP stockpiling | |
| Opportunity to reassess pain management, but concern about other analgesics | ||
| Withdrawal impact | Rather bad experience due to poor tolerance of other analgesics | |
| Complex pain management, but opportunity to educate patients | Poor acceptation | |
| Influence of past events | Distrust of the pharmaceutical industry and healthcare institutions | |
| Reduction of drugs available | ||
The perceptions common to both GPs and patients are in bold characters.